IL-6 released from MSCs stimulates the release of endothelin-1 (ET-1) in cancer cells, which in turn triggers the activation of Akt and ERK in endothelial cells, improving their ability to attract other cells to the tumor and promoting angiogenesis (227). Here, AKT1 is linked to cancer.